Japan’s MHLW Encourages Hospitals To Embrace Treatment-specific Reimbursement System
This article was originally published in PharmAsia News
Executive Summary
TOKYO - By July 2009, a total of 1,383 Japanese hospitals, out of some 9,000 hospitals in the country, will be recognized by Japan's Ministry of Health, Labor and Welfare as medical facilities to be evaluated by a "diagnosis procedure combination," similar to the U.S. diagnosis-related group system, to receive fixed-sum National Health Insurance reimbursements for treatments in MHLW-specified disease groups, an MHLW official told PharmAsia News April 6
You may also be interested in...
Drug Makers Expedite Switch OTC Development, Sales After Japan Law Revision
TOKYO - Japanese drug makers are stepping up development and sales of switch OTC drugs with the hope of gaining market share, a continuing ripple effect from the recent amendment on OTC pharmaceuticals
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).